Gynecologic Oncology
Clinical discussions on gynecologic malignancies, surgical approaches, and multimodal treatment strategies.
Recent Discussions
How would you manage a patient with a h/o HSIL & VAIN3 and recent colposcopic vaginal biopsies "highly concerning for exophytic pattern squamous cell carcinoma" refusing vaginectomy?
I have treated with image guided brachy. I use MRI for planning and a multichannel cylinder. Our dose is 6Gy x 5 or 7Gy x 5 prescribed to thickness of vagina seen on MRI, (varies across length) respecting doses to critical organs.
How do you manage vaginal dehiscence discovered during vaginal brachytherapy?
You need to withdraw the applicator and keep patient supine. The patient will require admission and emergent surgery to fix the defect, otherwise bowel loops may prolapse through the defect.
Does size influence your decision making for women with low or low-intermediate risk endometrial cancer after hysterectomy?
In otherwise low risk disease where I would favor observation, I do discuss pros and cons of adjuvant cuff brachytherapy if size greater than 2.5 cm or so.
Is it safe and/or necessary to combine osimertinib and carboplatin/paclixel for a patient with stage IV EGFR mutated NSCLC and advanced ovarian carcinoma?
This is a tough situation and a lot depends on the status and urgency of the ovarian cancer and whether surgery is planned for it. I would not combine the chemotherapy and osimertinib simultaneously for sure. There are several studies that show the combination of chemo and TKI is not as good as TKI ...
When would you recommend surgical debulking of pelvic or para-aortic lymph nodes in cervical cancer prior to definitive chemoradiation therapy?
We have not favored dissection and treated with SIB and sometimes added sequential boost ( EQ@ dose 58-66 Gy) based on sizemost current literature shows excellent regional control but high distant failure in these ptsfor bowel and duodenum ( two organs which could be limiting factor) we use v55 dose...
How would you treat a woman with an isolated vaginal cuff recurrence from endometrial cancer who has received salvage resection?
I would still consider for RT as limited data suggest higher nodal relapse if only local disease addressed I would treat pelvis with EBRT followed by brachy boost but to lower total dose of 60 to 65 Gy EQ2
How would you treat indeterminate non-PET avid sub-cm common iliac nodes in a patient with locally advanced cervical cancer?
It has to be interpreted with clinical context including stage of disease and nodal staging with PET. If multiple pet positive nodes in pelvis would treat with extended field up to renal vessels and boost any suspicious node as data suggest high risk of pa failure in these pts. If no pet avid node t...
When do you consider neoadjuvant chemotherapy prior to definitive chemoradiation for cervical cancer?
Although we are occassionally referred patients for "consolidation" of loco-regional disease after favorable responses to chemotherapy for stage IVB disease, we very rarely give neoadjuvant chemotherapy for patients with stage I-IVA cancers with nodal disease confined to the pelvis and PA regions. E...
How do you apply bolus and confirm daily air gaps/setup for vulvar cancer, especially for larger, fungating lesions?
For me, I am into "wet cotton gauze" wrapped in (new) plastic wrapping daily....for it is more conformal than even the old paraffin wax molds I used to use back in the day. Clearly, it is at best a 'guess-ti-mate' as to the thickness required for each case. But it does and has worked well in my expe...
With vaginal cuff brachytherapy, do you treat to active or treatment length?
There is no consensus what length to treat. The data for 2 to 5 cm appears to have similar outcomes. We treat 3 cm length so we have 7 dwell positions but as the rectovaginal septum thins out in the mid and lower vagina, the depth of prescription of 5 mm is usually in upper 2 cm or so only. Beyond t...